U.S. market Closed. Opens in 33 minutes

RVMD | Revolution Medicines, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue11.58M35.38M29.39M42.98M50.04M20.16MN/A
Cost of Revenue9.31M9.66M7.33M132.25M91.75MN/AN/A
Gross Profit2.27M25.72M22.06M-89.27M-41.71M20.16MN/A
Operating Expenses489.46M293.66M217.40M153.68M104.16M60.49M31.13M
Selling, General & Admin72.42M40.59M30.45M21.43M12.41M9.41M4.54M
Research & Development417.03M253.07M186.95M132.25M91.75M51.08M26.59M
Other Operating Expenses115.00KN/AN/AN/AN/A-2.12MN/A
Operating Income-487.19M-258.28M-188.01M-110.70M-54.12M-40.33M-31.13M
Other Expenses / Income47.29M9.15M917.00K2.17M2.08M-2.12M2.00K
Before Tax Income-439.89M-249.12M-187.09M-108.53M-52.04M-41.79M-31.13M
Income Tax Expenses-3.52M-420.00K-7.32M-371.00K-4.37M-1.34MN/A
Net Income-436.37M-248.71M-179.77M-108.16M-47.66M-41.79M-31.13M
Interest Expenses303.00K-9.66M12.00K71.00K106.00K116.00K103.00K
Basic Shares Outstanding113.15M80.63M72.81M66.60M59.00M36.47M36.47M
Diluted Shares Outstanding113.15M80.63M72.81M66.60M59.00M36.47M36.47M
EBITDA-477.88M-249.12M-187.08M-108.46M-48.59M-39.91M-29.84M
EBITDA Margin-4,126.74%-704.14%-636.54%-252.33%-97.10%-197.91%0.00%
EBIT-439.59M-258.78M-187.08M-108.46M-51.93M-43.02M-31.02M
EBIT Margin-3,796.10%-731.43%-636.54%-252.33%-103.78%-213.33%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙